BioCentury | Sep 8, 2014
Financial News

GC-Rise completes venture financing

...Autoimmune, Infectious Date completed: 2014-09-02 Type: Venture financing Raised: Not disclosed Investor: OrbiMed Advisors Note: GC-Rise...
BioCentury | May 17, 2010
Company News

Medigene, GC-Rise deal

...MediGene granted GC-Rise rights to commercialize Veregen polyphenon E in China. GC-Rise is responsible for clinical...
...licensed rights from Mitsui & Co. Ltd. (Tokyo:8031, Tokyo, Japan). MediGene AG (Xetra:MDG), Martinsried, Germany GC-Rise Pharmaceutical Co. Ltd....
Items per page:
1 - 2 of 2
BioCentury | Sep 8, 2014
Financial News

GC-Rise completes venture financing

...Autoimmune, Infectious Date completed: 2014-09-02 Type: Venture financing Raised: Not disclosed Investor: OrbiMed Advisors Note: GC-Rise...
BioCentury | May 17, 2010
Company News

Medigene, GC-Rise deal

...MediGene granted GC-Rise rights to commercialize Veregen polyphenon E in China. GC-Rise is responsible for clinical...
...licensed rights from Mitsui & Co. Ltd. (Tokyo:8031, Tokyo, Japan). MediGene AG (Xetra:MDG), Martinsried, Germany GC-Rise Pharmaceutical Co. Ltd....
Items per page:
1 - 2 of 2